TY  - JOUR
AU  - Sánchez-Rovira, Pedro
AU  - Pérez-Chica, Gerardo
AU  - Ortega-Granados, Ana Laura
AU  - Aguilar-García, Josefa
AU  - Díaz-Beltrán, Leticia
AU  - Gálvez-Montosa, Fernando
AU  - García-Verdejo, Francisco
AU  - Luque-Caro, Natalia
AU  - Quero-Blanco, Cristina
AU  - Fernández-Navarro, Mónica
AU  - Rodríguez-Sánchez, Agustín
AU  - Ruiz-Bailén, Manuel
AU  - Yaguez-Mateos, Luis
AU  - Marín-Pozo, Juan Francisco
AU  - Sierra-Torres, María Isabel
AU  - Lacárcel-Bautista, Celia
AU  - Duro-Ruiz, Gaspar Jesús
AU  - Duro-Fernández, María Ángeles
AU  - García-Alegría, Javier
AU  - Herrero-Rodríguez, Carmen
PY  - 2021
DO  - 10.1097/MD.0000000000026533
UR  - http://hdl.handle.net/10668/18381
T2  - Medicine
AB  - The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2, keeps spreading globally. Evidence suggests that a subgroup of patients with severe symptomatology might have cytokine storms, which increases...
LA  - en
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antibodies, Monoclonal, Humanized
KW  - COVID-19
KW  - Female
KW  - Humans
KW  - Intensive Care Units
KW  - Interleukin-6
KW  - Male
KW  - Middle Aged
KW  - Pneumonia, Viral
KW  - Prognosis
KW  - Retrospective Studies
KW  - COVID-19 Drug Treatment
TI  - Early use of tocilizumab in patients with severe pneumonia secondary to severe acute respiratory syndrome coronavirus 2 infection and poor prognostic criteria: Impact on mortality rate and intensive care unit admission.
TY  - research article
VL  - 100
ER  -